Metsera’s Impressive Clinical Data for Weight-Loss Drug Sparks Bidding War Among Pharma Giants

Life Science

U.S. Government Facilitates Historic Price Cut for Weight-Loss Drugs, with an Agreed Price of $245

Life Science

Novo Nordisk’s Weight-Loss Woes Worsen as It Cuts Guidance Again

Life Science

Teva Pharmaceutical’s Stock Soars on Better-Than-Expected Earnings

Life Science

Eli Lilly: High Growth Driven by GLP-1 Drugs and Potential Challenges

Life Science

Renaissance Group Bets $35M on Halozyme’s Subcutaneous Drug Delivery Disruption

Life Science

Beyond the Tech Titans: An AI Stock With a Different Kind of Disruption

Life Science, Technology

Experiments, Mergers, and Interest Rate Cuts: The Biotechnology Sector Ushers in a New Cycle

Life Science

Metsera’s Weight-Loss Drug Technology Sparks Bidding War Among Giants as Stock Price Quadruples in a Month

Life Science

Defensive Plays for a Bear Market: 3 Healthcare Stocks with Robust Dividends

Life Science

Three Canadian Growth Stocks Garner Unanimous “Strong Buy” Ratings from Analysts

Life Science

How is Pfizer Planning for the Future Under the Patent Cliff?

Life Science

Vertex Pharmaceuticals: Poised to Outpace Pfizer on Compelling Growth Story

Life Science

Defying Market Trend, Biotechnology Company Glaukos Soars Nearly 14%

Life Science

Seeking Certainty in Growth Stocks: Where to Invest for 2025

Financial Service, Life Science, Technology